Literature DB >> 32933912

Case of functioning thoracic paraganglioma.

Jinson Paul1, Felix K Jebasingh2, Thomas Alex Kodiatte3, Birla Roy Gnanamuthu4.   

Abstract

Functioning thoracic paraganglioma (PGL) is rare in clinical practice. We present a 33-year-old man with this pathology, who came with right-sided chest pain and was found to have a right-sided paravertebral mass. Fine needle aspiration cytology revealed a PGL. Urine normetanephrine was elevated and meta- iodobenzylguanidine scan showed increased tracer uptake in the right hemithorax, suggestive of a functioning neuroendocrine tumour. The patient was subjected to right PGL excision by video-assisted thoracoscopic surgery, after adequate preoperative preparations. The perioperative period was uneventful, except for a transient rise in blood pressure during the surgery. His blood pressure continued to be normal in the postoperative period. In any patient with a paravertebral mass, the possibility of PGL should be kept in mind even if the patient is normotensive. Making a preoperative diagnosis is important, because excision of functioning PGL without adequate preoperative preparation may be detrimental. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  adrenal disorders; cardiothoracic surgery; endocrinology

Mesh:

Year:  2020        PMID: 32933912      PMCID: PMC7493105          DOI: 10.1136/bcr-2020-236440

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  7 in total

1.  Paraganglioma of the mediastinum: challenges in diagnosis and surgical management.

Authors:  Ori Wald; Oz M Shapira; Aiman Murar; Uzi Izhar
Journal:  J Cardiothorac Surg       Date:  2010-03-31       Impact factor: 1.637

2.  Mediastinal Paraganglioma.

Authors:  Stephanie N Buchanan; Kevin M Radecki; Lowell W Chambers
Journal:  Ann Thorac Surg       Date:  2017-05       Impact factor: 4.330

3.  Anatomic Location Is the Primary Determinant of Survival for Paragangliomas.

Authors:  Trevan Fischer; Shrawan Gaitonde; Maris Jones; Bradley Bandera; Melanie Goldfarb
Journal:  Am Surg       Date:  2017-10-01       Impact factor: 0.688

4.  Mediastinal paragangliomas: association with mutations in the succinate dehydrogenase genes and aggressive behavior.

Authors:  Hans K Ghayee; Bas Havekes; Eleonora P M Corssmit; Graeme Eisenhofer; Stephen R Hammes; Zahid Ahmad; Alexander Tessnow; Ivica Lazúrová; Karen T Adams; Antonio T Fojo; Karel Pacak; Richard J Auchus
Journal:  Endocr Relat Cancer       Date:  2008-12-15       Impact factor: 5.678

5.  The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas.

Authors:  Nelly Burnichon; Vincent Rohmer; Laurence Amar; Philippe Herman; Sophie Leboulleux; Vincent Darrouzet; Patricia Niccoli; Dominique Gaillard; Gérard Chabrier; Frédéric Chabolle; Isabelle Coupier; Philippe Thieblot; Pierre Lecomte; Jérôme Bertherat; Nelly Wion-Barbot; Arnaud Murat; Annabelle Venisse; Pierre-François Plouin; Xavier Jeunemaitre; Anne-Paule Gimenez-Roqueplo
Journal:  J Clin Endocrinol Metab       Date:  2009-05-19       Impact factor: 5.958

6.  Clinical predictors and algorithm for the genetic diagnosis of pheochromocytoma patients.

Authors:  Zoran Erlic; Lisa Rybicki; Mariola Peczkowska; Henriette Golcher; Peter H Kann; Michael Brauckhoff; Karsten Müssig; Michaela Muresan; Andreas Schäffler; Nicole Reisch; Matthias Schott; Martin Fassnacht; Giuseppe Opocher; Silke Klose; Christian Fottner; Flavio Forrer; Ursula Plöckinger; Stephan Petersenn; Dimitry Zabolotny; Oleg Kollukch; Svetlana Yaremchuk; Andrzej Januszewicz; Martin K Walz; Charis Eng; Hartmut P H Neumann
Journal:  Clin Cancer Res       Date:  2009-10-13       Impact factor: 12.531

7.  Mutations seen among patients with pheochromocytoma and paraganglioma at a referral center from India.

Authors:  R Pai; A Ebenazer; M J Paul; N Thomas; A Nair; M S Seshadri; R Oommen; N Shanthly; A Devasia; G Rebekah; L Jeyaseelan; S Rajaratnam
Journal:  Horm Metab Res       Date:  2014-06-30       Impact factor: 2.936

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.